首页 > 市场调查报告书 > 医疗设备

麻醉

市场调查报告书

商品编码

1547624

全球吸入麻醉市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Inhalation Anesthesia Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球吸入麻醉市场需求预计将从2023年的20.8亿美元达到2032年近47.3亿美元的市场规模，2024-2032年研究期间复合年增长率为9.56%。

吸入麻醉剂用于手术室全身麻醉的诱导和维持。最常见的吸入麻醉剂是地氟烷、异氟烷、一氧化二氮、七氟烷和氙。吸入麻醉剂经由肺部进入体内，并经由血液输送到组织。已知的吸入麻醉剂应用是镇静、难治性支气管痉挛以及控制对抗惊厥药物无反应的癫痫持续状态。

市场动态

患有各种疾病（包括癌症、心血管疾病、脊椎疾病、骨科疾病、呼吸系统疾病、胃肠道疾病、神经系统疾病等）的老龄化人口数量不断增加，预计将刺激这一增长。侵入性手术数量的增加也导致了需求的增加。紧急病例数量的增加以及吸入麻醉剂相对注射麻醉剂的优势也加速了市场的成长。然而，与吸入麻醉药物相关的副作用，如心律不整、神经毒性、术后噁心和呕吐、呼吸抑制和刺激，预计将在预测期内阻碍生长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球吸入麻醉市场的各个细分市场进行了包容性评估。吸入麻醉产业的成长和趋势为本研究提供了整体方法。

市场区隔

吸入麻醉市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按药物分类

七氟醚
地氟烷
异氟烷
其他的

按申请

就职
维护

按最终用途

医院
门诊手术中心
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲吸入麻醉市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。吸入麻醉市场的主要参与者包括 Halocarbon Products Corporation、百特、艾伯维、鲁南製药集团等。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：吸入麻醉公司的竞争格局

吸入麻醉市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Halocarbon Products Corporation

公司概况
公司收入
产品
最新动态

Baxter

公司概况
公司收入
产品
最新动态

AbbVie

公司概况
公司收入
产品
最新动态

Lunan Pharmaceutical Group

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11214299

The global demand for Inhalation Anesthesia Market is presumed to reach the market size of nearly USD 4.73 Billion by 2032 from USD 2.08 Billion in 2023 with a CAGR of 9.56% under the study period 2024-2032.

Inhalation anesthetics are used for induction and maintenance of general anesthesia in the operating room. The most common inhalational anesthetics are desflurane, isoflurane, nitrous oxide, sevoflurane, and xenon. Inhalation anesthetics work by entering the body through the lungs and are carried by the blood to tissues. The known inhaled anesthetic applications are sedation, refractory bronchospasm, and control of status epilepticus unresponsive to anticonvulsant medications.

MARKET DYNAMICS

Expanding aging population suffering from various diseases, including cancer, disorders related to cardiovascular, spinal, orthopedic, respiratory, gastrointestinal, neurological, and others are anticipated to stimulate the growth. The increasing number of invasive procedures is also contributing to the demand increase. The rise in the number of emergency cases and the benefit of inhalation anesthetics over injectable anesthetics is also accelerating the market's growth. However, Side effects associated with Inhalation anesthetics such as cardiac arrhythmias, neurotoxicity, postoperative nausea and vomiting, respiratory depression, and irritation are foreseen to impede growth during the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Inhalation Anesthesia. The growth and trends of Inhalation Anesthesia industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Inhalation Anesthesia market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug

Sevoflurane
Desflurane
Isoflurane
Others

By Application

Induction
Maintenance

By End-use

Hospitals
Ambulatory Surgical Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Inhalation Anesthesia market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Inhalation Anesthesia market include Halocarbon Products Corporation, Baxter, AbbVie, Lunan Pharmaceutical Group, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. INHALATION ANESTHESIA - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL INHALATION ANESTHESIA MARKET ANALYSIS BY DRUG

5.1. Overview By Drug
5.2. Historical and Forecast Data
5.3. Analysis By Drug
5.4. Sevoflurane Historic and Forecast Sales By Regions
5.5. Desflurane Historic and Forecast Sales By Regions
5.6. Isoflurane Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL INHALATION ANESTHESIA MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Induction Historic and Forecast Sales By Regions
6.5. Maintenance Historic and Forecast Sales By Regions

7. GLOBAL INHALATION ANESTHESIA MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data
7.3. Analysis By End-use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL INHALATION ANESTHESIA MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE INHALATION ANESTHESIA COMPANIES

9.1. Inhalation Anesthesia Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF INHALATION ANESTHESIA INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Halocarbon Products Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Baxter
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. AbbVie
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Lunan Pharmaceutical Group
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments